ArticleAnnals of vascular diseases2026
Effect of Drug-Coated Balloons on Recurrent Venous Hypertension Due to Central Venous Lesions in Patients with Hemodialysis Vascular Access.
Article in Annals of vascular diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to evaluate the efficacy of drug-coated balloons (DCBs) for symptomatic and recurrent central venous lesions (including in-stent restenosis and occlusion) in patients undergoing hemodialysis. Methods: Twenty-seven patients treated with DCBs for symptomatic central venous lesions between June 2021 and September 2025 were included. We examined the overall efficacy of DCBs, the outcomes of repeated use, and factors affecting patency. Results: Target lesion patency at 6 months was significantly improved following initial DCB use (77% vs. 30% prior to DCB use, p <0.0001). The efficacy of repeated DCB use was not significantly different between the first and second applications. In a subgroup analysis, there was a trend toward better patency rates in patients treated with peripheral cutting balloons (PCBs) for pre-dilatation compared to those treated with conventional balloons, although the difference was not statistically significant. Conclusions: DCBs demonstrated satisfactory efficacy for recurrent central venous lesions, which was maintained with repeated use. Additionally, pre-dilatation using PCBs showed a trend toward improved patency rates. (This is a translation of Jpn J Vasc Surg 2026; 35: 23-28.).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.